Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant. Leuk Lymphoma 2021 Jan;62(1):229-233
Date
09/15/2020Pubmed ID
32924688Pubmed Central ID
PMC7939047DOI
10.1080/10428194.2020.1817446Scopus ID
2-s2.0-85090933926 (requires institutional sign-in at Scopus site) 1 CitationAuthor List
Dhakal B, Wang T, Kuxhausen M, Zhu F, Taylor C, Spellman SR, Verneris MR, Hsu K, Fleischhauer K, Lee SJ, Bolon YT, Carlson KS, Nazha A, Saber WAuthors
Karen-Sue B. Carlson MD, PhD Associate Professor in the Medicine department at Medical College of WisconsinBinod Dhakal MD Associate Professor in the Medicine department at Medical College of Wisconsin
Wael Saber MD, MS Professor in the Medicine department at Medical College of Wisconsin
Tao Wang PhD Associate Professor in the Data Science Institute department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Chemokines, CXCHematopoietic Stem Cell Transplantation
Humans
Ligands
Myelodysplastic Syndromes
Prognosis